Here’s the short version: Xenex, a Colorado-based manufacturer of electrotherapy devices for pain management, reportedly made its money not by selling good products, but by filling patients with supplies they never asked for — electrode pads, batteries, the works — and then billing insurers for all of it. According to a federal indictment unsealed on or around January 21, 2026, former CEO Thomas Sandgaard and former COO Anna Luksok caused the company to collect more than $873 million, of which more than $600 million came from supplies. The indictment states that the vast majority of supply bills were billed unnecessarily and improperly, amounting to 32, 64 or even 128 electrode pairs per patient per month.
Xynex class action alleges $873 million insurance overbilling scheme & more related News Here
